Ondansan I.V. (Ondansetron)

Ondansetron, the active ingredient in Ondansan I.V., is a 5-HT3 receptor antagonist presented as an intravenous solution for injection use. It is employed to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery in adult and pediatric patients. GNH USA supplies Ondansan I.V. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Ondansan I.V. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Ondansetron acts on the serotonergic pathway to control nausea and vomiting. - Chemotherapy‑induced nausea and vomiting (CINV): helps reduce the frequency and severity of acute and delayed episodes. - Radiation‑induced nausea and vomiting (RINV): provides prophylactic control of nausea during and after radiotherapy. - Post‑operative postoperative post‑    ...